[Rifaximin for hepatic encephalopathy in children. Case report].
Rifaximin is an antibiotic recently approved for the treatment of hepatic encephalopathy in adults. In children more than 12 year-old, it has been approved for travelers' diarrhea and it is also widely used in inflammatory bowel disease. We report, to our knowledge, the first case of a pediatric patient who received rifaximin for hepatic encephalopathy with good clinical outcome.
Hepatología y trasplante hepático pediátrico, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina. imalla@cas.austral.edu.ar
Ivone
I
Malla
Verónica
V
Torres Cerino
Andrés
A
Villa
Yu
Y
Cheang
Gisela
G
Giacove
Alejandra
A
Pedreira
Marcelo
M
Silva
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin
D000890:Anti-Infective Agents; D012294:Rifamycins; D000078262:Rifaximin